The average cost for a Big Pharma ... more intricate and complex research areas, macroeconomic factors, tech advancements and high attrition rates; the pharma cohort spent $7.7 billion on trials ...

With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that ... be analysed during drug discovery and research, and is accelerating the pace ...

Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why outsourcing innovation can be as risky, and costly, as internal discovery.

But if the business needs to reduce costs, the chemist might work on developing a food with a longer shelf life. Product Development: Once applied research has identified a workable solution to a ...

The pharmaceutical industry has long been reliant on rigorous research and development processes to ... reducing the time and cost once associated with bringing new drugs to market.

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

A report claimed that employees in the age group of 50-55 years working in Dr Reddy’s research and development (R&D) division ...

Adeosun urged Tinubu to redouble efforts at tackling the rising cost of drugs ... engagement of exited pharmaceutical companies to bring back investment in Research and Development (R&D) to ...